Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-08
1996-05-28
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, 530314, A61K 3808
Patent
active
055211585
ABSTRACT:
The invention relates to peptides of up to 10 amino acids that are synthesized by substituting at least one of the bradykinin amino acids found in positions 2, 3, 4 and 5 of the bradykinin peptide with a fatty acid amine. The modified bradykinin peptides produced confer increased resistance to enzymatic degradation and/or tissue specificity. The invention also relates to pharmaceutical preparations and processes of treatments using the modified bradykinin peptides.
REFERENCES:
patent: 4242329 (1980-12-01), Claeson et al.
patent: 4693993 (1987-09-01), Stewart et al.
patent: 4801613 (1989-01-01), Stewart et al.
patent: 5385889 (1995-01-01), Kyle
Journal of Medicine Chemistry, 1991, vol. 34, No. 8, pp. 2649-2653.
Kyle Donald J.
Mavunkel Babu J.
Chan Christina Y.
Chong Suet M.
Lukton David
Nath Gary M.
Scios Nova Inc.
LandOfFree
Pseudopeptide bradykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pseudopeptide bradykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudopeptide bradykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-786746